Gastrointestinal Endoscopy
Volume 70, Issue 5 , Pages 907-914 , November 2009

EUS-FNA predicts 5-year survival in pancreatic endocrine tumors

Received 17 November 2008 ,Accepted 6 May 2009.

References 

  1. Fitzgerald TL, Hickner ZJ, Schmitz M, et al. Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry. Pancreas. 2008;37:134–138
  2. Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology. 2008;135:1469–1492
  3. Ito T, Tanaka M, Sasano H, et al. Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumors. J Gastroenterol. 2007;42:497–500
  4. Jani N, Khalid A, Kaushik N, et al. EUS-guided FNA diagnosis of pancreatic endocrine tumors: new trends identified. Gastrointest Endosc. 2008;67:44–50
  5. Artale S, Giannetta L, Cerea G, et al. Treatment of metastatic neuroendocrine carcinomas based on WHO classification. Anticancer Res. 2005;25:4463–4469
  6. Bajetta E, Catena L, Procopio G, et al. Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?. Ann Oncol. 2005;16:1374–1380
  7. Plockinger U, Rindi G, Arnold R, et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology. 2004;80:394–424
  8. Kloppel G. Tumour biology and histopathology of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab. 2007;21:15–31
  9. Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci. 2004;1014:13–27
  10. Chatzipantelis P, Salla C, Konstantinou P, et al. Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic neuroendocrine tumors: a study of 48 cases. Cancer. 2008;114:255–262
  11. McLean AM, Fairclough PD. Endoscopic ultrasound in the localisation of pancreatic islet cell tumours. Best Pract Res Clin Endocrinol Metab. 2005;19:177–193
  12. Anderson MA, Carpenter S, Thompson NW, et al. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol. 2000;95:2271–2277
  13. Ardengh JC, de Paulo GA, Ferrari AP. EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. Gastrointest Endosc. 2004;60:378–384
  14. Pais S, McGreevy K, Leblanc J, et al. Utility of EUS-FNA in the diagnosis of pancreatic neuroendocrine tumors: correlation with histopathology in 76 patients. Gastrointest Endosc. 2007;65:AB304
  15. Que FG, Sarmiento JM, Nagorney DM. Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors. Cancer Control. 2002;9:67–79
  16. Thompson GB, van Heerden JA, Grant CS, et al. Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery. 1988;104:1011–1017
  17. Sellner F, Sobhian B, De Santis M, et al. Well or poorly differentiated nonfunctioning neuroendocrine carcinoma of the pancreas: a single institution experience with 17 cases. Eur J Surg Oncol. 2008;34:191–195
  18. Ramage J, Davies A, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut. 2005;54:iv1–iv16
  19. Pape UF, Jann H, Muller-Nordhorn J, et al. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer. 2008;113:256–265

 DISCLOSURE: All authors disclosed no financial relationships relevant to this publication.

 If you would like to chat with an author of this article, you may contact him at faff@gbl.com.br.

PII: S0016-5107(09)01922-1

doi: 10.1016/j.gie.2009.05.020

Gastrointestinal Endoscopy
Volume 70, Issue 5 , Pages 907-914 , November 2009

Article Tools

* Image Usage & Resolution